Mark Baldry
Corporate Officer/Principal bei X4 PHARMACEUTICALS, INC.
Vermögen: 27 900 $ am 30.04.2024
Aktive Positionen von Mark Baldry
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Corporate Officer/Principal | 26.11.2022 | - |
Karriereverlauf von Mark Baldry
Ehemalige bekannte Positionen von Mark Baldry
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Corporate Officer/Principal | 01.08.2019 | 01.02.2020 |
| AMICUS THERAPEUTICS, INC. | Vertrieb & Marketing | 08.06.2015 | 01.07.2019 |
| BIOGEN INC. | Public Communications Contact | - | 01.05.2015 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 02.11.2020 | - |
| WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | 06.08.2019 | - |
| SHIRE | Corporate Officer/Principal | - | - |
Ausbildung von Mark Baldry
| Concordia University | Masters Business Admin |
| York University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
| Irland | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Sales & Marketing | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Utilities | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Utilities |
- Börse
- Insiders
- Mark Baldry
- Erfahrung
